Using transgenic plants and modified plant viruses for the development of treatments for human diseases

Graphical abstract

• Publication year

  2017

• Venue

  Current Opinion in Virology

• Publication date

  2017-08-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.coviro.2017.07.019PMID 28800551PMCID 7102806
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Purification and immunogenicity of hemagglutinin from highly pathogenic avian influenza virus H5N1 expressed in Nicotiana benthamiana

  2017cited by this paper
• Expression of an immunogenic LTB-based chimeric protein targeting Zaire ebolavirus epitopes from GP1 in plant cells

  2017cited by this paper
• Antigen Production in Plant to Tackle Infectious Diseases Flare Up: The Case of SARS

  2016cited by this paper
• Immunological Characterization of Plant-Based HIV-1 Gag/Dgp41 Virus-Like Particles

  2016cited by this paper
• Study of the immunogenicity of hepatitis B surface antigen synthesized in transgenic potato plants with increased biosafety.

  2015cited by this paper
• When plant virology met Agrobacterium: the rise of the deconstructed clones

  2015cited by this paper
• Gene Delivery into Plant Cells for Recombinant Protein Production

  2015cited by this paper
• Plants as Factories for Human Pharmaceuticals: Applications and Challenges

  2015cited by this paper
• Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants.

  2015cited by this paper
• Expression of H3N2 nucleoprotein in maize seeds and immunogenicity in mice

  2015cited by this paper
• A Plant-Derived Multi-HIV Antigen Induces Broad Immune Responses in Orally Immunized Mice

  2015cited by this paper
• Novel vaccination approach for dengue infection based on recombinant immune complex universal platform.

  2015cited by this paper
• Oral delivery of Acid Alpha Glucosidase epitopes expressed in plant chloroplasts suppresses antibody formation in treatment of Pompe mice.

  2015cited by this paper
• Expression of Rabies Glycoprotein and Ricin Toxin B Chain (RGP–RTB) Fusion Protein in Tomato Hairy Roots: A Step Towards Oral Vaccination for Rabies

  2015cited by this paper
• Plant-based oral delivery of β-glucocerebrosidase as an enzyme replacement therapy for Gaucher's disease.

  2015cited by this paper
• Low cost industrial production of coagulation factor IX bioencapsulated in lettuce cells for oral tolerance induction in hemophilia B.

  2015cited by this paper
• Immunogenicity of H1N1 influenza virus-like particles produced in Nicotiana benthamiana

  2015cited by this paper
• Immunization with an HPV-16 L1-based chimeric virus-like particle containing HPV-16 E6 and E7 epitopes elicits long-lasting prophylactic and therapeutic efficacy in an HPV-16 tumor mice model

  2014cited by this paper
• Freeze-Drying of Plant Tissue Containing HBV Surface Antigen for the Oral Vaccine against Hepatitis B

  2014cited by this paper
• Suppression of inhibitor formation against FVIII in a murine model of hemophilia A by oral delivery of antigens bioencapsulated in plant cells.

  2014cited by this paper
• Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp™

  2014cited by this paper
• Generation and Analysis of Novel Plant-Derived Antibody-Based Therapeutic Molecules against West Nile Virus

  2014cited by this paper
• Plant Virus Expression Vector Development: New Perspectives

  2014cited by this paper
• Structural and functional characterization of an anti-West Nile virus monoclonal antibody and its single-chain variant produced in glycoengineered plants.

  2014cited by this paper
• Generation of protective immune response against anthrax by oral immunization with protective antigen plant-based vaccine.

  2014cited by this paper
• A Plant-Produced Antigen Elicits Potent Immune Responses against West Nile Virus in Mice

  2014cited by this paper
• Comparative Evaluation of Recombinant Protein Production in Different Biofactories: The Green Perspective

  2014cited by this paper
• Immunization with an HPV-16 L1-based chimeric virus-like particle containing HPV-16 E6 and E7 epitopes elicits long-lasting prophylactic and therapeutic efficacy in an HPV-16 tumor mice model

  2013cited by this paper
• A plant-produced protective antigen vaccine confers protection in rabbits against a lethal aerosolized challenge with Bacillus anthracis Ames spores

  2013cited by this paper
• Therapeutic Intervention of Ebola Virus Infection in Rhesus Macaques with the MB-003 Monoclonal Antibody Cocktail

  2013cited by this paper
• A plant-produced H1N1 trimeric hemagglutinin protects mice from a lethal influenza virus challenge

  2013cited by this paper
• Transgenic tobacco expressed HPV16-L1 and LT-B combined immunization induces strong mucosal and systemic immune responses in mice

  2013cited by this paper
• Reconstituted plant viral capsids can release genes to mammalian cells.

  2013cited by this paper
• Oral delivery of bioencapsulated exendin-4 expressed in chloroplasts lowers blood glucose level in mice and stimulates insulin secretion in beta-TC6 cells.

  2013cited by this paper
• Immunogenic properties of a lettuce-derived C4(V3)6 multiepitopic HIV protein

  2013cited by this paper
• Shire drops 'emergency' Fabry's disease drug

  2012cited by this paper
• First plant-made biologic approved

  2012cited by this paper
• Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development

  2012cited by this paper
• Improvement of the Trivalent Inactivated Flu Vaccine Using PapMV Nanoparticles

  2011cited by this paper
• Expression of an immunogenic Ebola immune complex in Nicotiana benthamiana.

  2011cited by this paper
• Intravital imaging of human prostate cancer using viral nanoparticles targeted to gastrin-releasing Peptide receptors.

  2011cited by this paper
• A non-glycosylated, plant-produced human monoclonal antibody against anthrax protective antigen protects mice and non-human primates from B. anthracis spore challenge

  2011cited by this paper
• Cowpea mosaic virus nanoparticles target surface vimentin on cancer cells.

  2011cited by this paper
• Clinical development of plant-produced recombinant pharmaceuticals: Vaccines, antibodies and beyond

  2011cited by this paper
• The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza.

  2010cited by this paper
• Plant‐made vaccines for humans and animals

  2010cited by this paper
• Production of antibodies in plants: status after twenty years.

  2010cited by this paper
• Production of vaccines and therapeutic antibodies for veterinary applications in transgenic plants: an overview

  2007cited by this paper
• A launch vector for the production of vaccine antigens in plants

  2007cited by this paper
• Introduction to Plant Viruses, the Invisible Foe.

  2006cited by this paper
• Plant viral capsids as nanobuilding blocks: construction of arrays on solid supports.

  2006cited by this paper
• Magnifection--a new platform for expressing recombinant vaccines in plants.

  2005cited by this paper
• Engineering the chloroplast genome for hyperexpression of human therapeutic proteins and vaccine antigens.

  2004cited by this paper
• Genetic modification: The production of recombinant pharmaceutical proteins in plants

  2003cited by this paper
• Production of secretory IgA antibodies in plants.

  2001cited by this paper
• The integration of T-DNA into plant genomes

  1996cited by this paper
• The expression of a nopaline synthase — human growth hormone chimaeric gene in transformed tobacco and sunflower callus tissue

  1986cited by this paper

• Novel applications of the tomato microbiome: Roles and considerations for agriculture, human health, and society

  2025cites this paper
• Cryopreservation of Rubus viruses in raspberry shoot tips via droplet-vitrification: assessment of viral preservation, localization, and post-thaw transmission capacity

  2025cites this paper
• Developments in the Production of Recombinant Monoclonal Antibodies

  2025cites this paper
• Addressing Various Strategies for Combating the Leaf‐Roll Virus in Potato Plants

  2025cites this paper
• Genome-Wide Analysis of the JAZ Gene Family in Potato and Functional Verification of StJAZ23 Under Drought Stress

  2025cites this paper
• Therapeutic proteins: developments, progress, challenges, and future perspectives

  2024cites this paper
• Plant-made pharmaceuticals

  2024cites this paper
• Patent characteristics for leishmaniasis treatment as a basis for freedom-to-operate analysis

  2024cites this paper
• Expression of recombinant human Apolipoprotein A-IMilano in Nicotiana tabacum

  2023cites this paper
• A Neutralizing Antibody Targeting gH Provides Potent Protection against EBV Challenge In Vivo

  2022cites this paper
• Safety and immunogenicity studies in animal models support clinical development of a bivalent norovirus-like particle vaccine produced in plants.

  2022cites this paper
• ANTIOXIDANTLY-MODULATIVE, CHEMOPREVENTIVE AND ANTI-SARS-COVID 19 ACTION OF MEDICINAL PLANTS

  2022cites this paper
• 1Progress, applications, challenges and prospects of protein purification technology

  2022cites this paper
• Ameliorating Fibrosis in Murine and Human Tissues with END55, an Endostatin-Derived Fusion Protein Made in Plants

  2022cites this paper
• A Review On Edible Vaccines And Biopharmaceutical Products From Plants.

  2022cites this paper
• Plant-Derived Human Vaccines: Recent Developments

  2022cites this paper
• Using the Strategy of Inducing and Genetically Transforming Plant Suspension Cells to Produce High Value-Added Bioactive Substances.

  2022cites this paper
• Plant-derived VLP: a worthy platform to produce vaccine against SARS-CoV-2

  2021cites this paper
• Comparative whole-genome and proteomics analyses of the next seed bank and the original master seed bank of MucoRice-CTB 51A line, a rice-based oral cholera vaccine

  2021cites this paper
• Hepatitis B core-based virus-like particles: A platform for vaccine development in plants

  2021cites this paper
• Research Trends in Genetically Modified (GM) Plants

  2021cites this paper
• Recombinant active Peptides and their Therapeutic functions.

  2021cites this paper
• Combating Human Viral Diseases: Will Plant-Based Vaccines Be the Answer?

  2021cites this paper
• Plant-based vaccine research development against viral diseases with emphasis on Ebola virus disease: A review study.

  2021cites this paper
• Establishment of the Carrot-Made LTB-Syn Antigen Cell Line in Shake Flask and Airlift Bioreactor Cultures

  2021cites this paper
• Plant-Based Vaccines Against Infectious Human Viral Diseases: Spotlight on HIV Vaccines

  2021cites this paper
• Highly sensitive and specific graphene/TiO2 impedimetric immunosensor based on plant-derived tetravalent envelope glycoprotein domain III (EDIII) probe antigen for dengue diagnosis.

  2020cites this paper
• Mosses in biotechnology.

  2020cites this paper
• Expression of a Functional Recombinant Human Glycogen Debranching Enzyme (hGDE) in N. benthamiana Plants and in Hairy Root Cultures.

  2020cites this paper
• Generation and In-planta expression of a recombinant single chain antibody with broad neutralization activity on Bothrops pauloensis snake venom.

  2020cites this paper
• Plant-made HIV vaccines and potential candidates.

  2020cites this paper
• Expression of Human papillomavirus type 52 L1 capsid gene in Oryza sativa involved in cytoprotective activities

  2020cites this paper
• Heterologous expression of biologically active Mambalgin-1 peptide as a new potential anticancer, using a PVX-based viral vector in Nicotiana benthamiana

  2020cites this paper
• Plant-based vaccines and antibodies to combat COVID-19: current status and prospects

  2020cites this paper
• The role of plant expression platforms in biopharmaceutical development: possibilities for the future

  2019cites this paper
• Bioproduction of a Therapeutic Vaccine Against Human Papillomavirus in Tomato Hairy Root Cultures

  2019cites this paper
• Plant Viruses in Plant Molecular Pharming: Toward the Use of Enveloped Viruses

  2019cites this paper
• Review on New Plant Breeding Techniques

  2019cites this paper
• Epitope Presentation of Dengue Viral Envelope Glycoprotein Domain III on Hepatitis B Core Protein Virus-Like Particles Produced in Nicotiana benthamiana

  2019cites this paper
• Recent Developments in Bioprocessing of Recombinant Proteins: Expression Hosts and Process Development

  2019cites this paper
• A Brief Reminder of Systems of Production and Chromatography-Based Recovery of Recombinant Protein Biopharmaceuticals

  2019cites this paper
• Molecular farming of antimicrobial peptides: available platforms and strategies for improving protein biosynthesis using modified virus vectors.

  2019cites this paper
• Molecular farming for therapies and vaccines in Africa.

  2019cites this paper
• Plant Platform for Therapeutic Monoclonal Antibody Production

  2019cites this paper
• Plant virus-based materials for biomedical applications: Trends and prospects.

  2019cites this paper
• Long-term preservation of potato leafroll virus, potato virus S, and potato spindle tuber viroid in cryopreserved shoot tips

  2018cites this paper
• Engineering Plants for the Future: Farming with Value-Added Harvest

  2018influential citation
• The Multiplanetary Future of Plant Synthetic Biology

  2018cites this paper
• Cryopreservation of virus: a novel biotechnology for long-term preservation of virus in shoot tips

  2018cites this paper
• Molecular pharming of consensus dengue viral envelope glycoprotein domain III in planta and its immunogenicity profiles in BALB/c mice

  2018cites this paper
• Repurposing Plant Virus Nanoparticles

  2018cites this paper
• Transient expression of virus-like particles in plants: a promising platform for rapid vaccine production

  2017cites this paper